Antimalarial drugs and artesunate

NEW YORK, July 24 (Praxis Press) Plasmodium falciparum has developed resistance to most of currently available antimalarial drugs; as a result, malaria remains a serious health problem in some tropical areas. Nosten and colleagues studied the effectiveness of combined artesunate-mefloquine treatment for the treatment of malaria in Thailand. The introduction of combined treatment countered an increasing resistance to mefloquine monotherapy and a falling cure rate. Combined artesunate-mefloquine a

July 25, 2000

NEW YORK, July 24 (Praxis Press) Plasmodium falciparum has developed resistance to most of currently available antimalarial drugs; as a result, malaria remains a serious health problem in some tropical areas. Nosten and colleagues studied the effectiveness of combined artesunate-mefloquine treatment for the treatment of malaria in Thailand. The introduction of combined treatment countered an increasing resistance to mefloquine monotherapy and a falling cure rate. Combined artesunate-mefloquine achieved a cure rate of 100% and decreased the incidence of malaria. Using artesunate in combination with conventional antimalarial drugs can prevent resistance.

Advertisement
Keystone Symposia
Keystone Symposia

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
Panasonic
Panasonic

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
The Scientist
The Scientist